MOTT RICHARD W
Known title: DirectorCIK: 0001210226
MOTT RICHARD W's purchase track record
MOTT RICHARD W has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/22/2024 | TMCI | $154K | +21.0% | +49.7% | +11.5% |
| 5/10/2024 | TMCI | $541K | +32.2% | +83.6% | +14.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TMCI | ▲ Buy | Grant | 23,917 | $0 | 5/20/2025 | View on chart |
| TMCI | ▲ Buy | Open Market | 18,000 | $94K | 5/24/2024 | View on chart |
| TMCI | ▲ Buy | Open Market | 12,100 | $60K | 5/22/2024 | View on chart |
| TMCI | ▲ Buy | Grant | 15,091 | $0 | 5/21/2024 | View on chart |
| TMCI | ▲ Buy | Open Market | 36,802 | $161K | 5/13/2024 | View on chart |
| TMCI | ▲ Buy | Open Market | 83,198 | $380K | 5/10/2024 | View on chart |
| TMCI | ▲ Buy | Grant | 2,753 | $0 | 5/23/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 4,043 | $105K | 4/6/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 15,756 | $410K | 4/4/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 201 | $5K | 4/3/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 95,000 | $2.4M | 3/31/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 38,498 | $1.0M | 3/30/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 1,502 | $39K | 3/9/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 25,000 | $563K | 3/8/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 20,000 | $480K | 3/8/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 50,000 | $1.1M | 3/1/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 4,011 | $96K | 2/2/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 61,528 | $1.4M | 1/30/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 27,422 | $655K | 1/30/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 2,039 | $50K | 1/30/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 11,014 | $286K | 1/17/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 6,519 | $169K | 1/13/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 42,467 | $1.1M | 1/12/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 10,444 | $251K | 1/9/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 9,556 | $229K | 1/5/2023 | View on chart |
| TMCI | ▼ Sell | Open Market | 75,000 | $1.7M | 12/30/2022 | View on chart |
| TMCI | ▼ Sell | Open Market | 20,000 | $480K | 12/1/2022 | View on chart |
| TMCI | ▼ Sell | Open Market | 75,000 | $1.6M | 11/30/2022 | View on chart |
| TMCI | ▼ Sell | Open Market | 95,000 | $2.2M | 10/31/2022 | View on chart |
| TMCI | ▲ Buy | Grant | 2,295 | $0 | 5/17/2022 | View on chart |
| TMCI | ▼ Sell | Gift | 105,000 | $0 | 3/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Treace Medical Shares Five-Year Bunion Study Results
Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.
Treace Medical Shares Five-Year Bunion Study Results. Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.